AU2003253050A8 - Diagnosis and therapy of breast tumours resistant to antiestrogen treatment - Google Patents

Diagnosis and therapy of breast tumours resistant to antiestrogen treatment

Info

Publication number
AU2003253050A8
AU2003253050A8 AU2003253050A AU2003253050A AU2003253050A8 AU 2003253050 A8 AU2003253050 A8 AU 2003253050A8 AU 2003253050 A AU2003253050 A AU 2003253050A AU 2003253050 A AU2003253050 A AU 2003253050A AU 2003253050 A8 AU2003253050 A8 AU 2003253050A8
Authority
AU
Australia
Prior art keywords
diagnosis
therapy
breast tumours
antiestrogen treatment
tumours resistant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003253050A
Other versions
AU2003253050A1 (en
Inventor
Iduna Fichtner
Vladimir Besada Perez
Michael Becker
Serra Lila Castellanos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CT FOR GENETIC ENGINEERING AND
Centro de Ingenieria Genetica y Biotecnologia CIGB
Max Delbrueck Centrum fuer Molekulare in der Helmholtz Gemeinschaft
Original Assignee
CT FOR GENETIC ENGINEERING AND
Centro de Ingenieria Genetica y Biotecnologia CIGB
Max Delbrueck Centrum fuer Molekulare in der Helmholtz Gemeinschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10310198A external-priority patent/DE10310198A1/en
Application filed by CT FOR GENETIC ENGINEERING AND, Centro de Ingenieria Genetica y Biotecnologia CIGB, Max Delbrueck Centrum fuer Molekulare in der Helmholtz Gemeinschaft filed Critical CT FOR GENETIC ENGINEERING AND
Publication of AU2003253050A8 publication Critical patent/AU2003253050A8/en
Publication of AU2003253050A1 publication Critical patent/AU2003253050A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2003253050A 2002-07-12 2003-07-10 Diagnosis and therapy of breast tumours resistant to antiestrogen treatment Abandoned AU2003253050A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10231873.5 2002-07-12
DE10231873 2002-07-12
DE10310198.5 2003-03-06
DE10310198A DE10310198A1 (en) 2002-07-12 2003-03-06 Methods for the diagnosis and therapy of anti-estrogen therapy-resistant breast tumors
PCT/EP2003/007449 WO2004008137A2 (en) 2002-07-12 2003-07-10 Diagnosis and therapy of breast tumours resistant to antiestrogen treatment

Publications (2)

Publication Number Publication Date
AU2003253050A8 true AU2003253050A8 (en) 2004-02-02
AU2003253050A1 AU2003253050A1 (en) 2004-02-02

Family

ID=30116640

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003253050A Abandoned AU2003253050A1 (en) 2002-07-12 2003-07-10 Diagnosis and therapy of breast tumours resistant to antiestrogen treatment

Country Status (2)

Country Link
AU (1) AU2003253050A1 (en)
WO (1) WO2004008137A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005123944A1 (en) * 2004-06-18 2005-12-29 Roche Diagnostics Gmbh Use of protein pdx1 as a marker for breast cancer
CN102346190A (en) * 2011-01-24 2012-02-08 中国人民解放军第三军医大学 Double-antibody sandwich ELISA reagent kit and method for detecting hyperoxide reductase IV in biological sample and application of reagent kit

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001238700A1 (en) * 2000-02-22 2001-09-03 Board Of Regents, The University Of Texas System Compositions and methods of use of het, a novel modulator of estrogen action

Also Published As

Publication number Publication date
WO2004008137A3 (en) 2004-09-02
WO2004008137A2 (en) 2004-01-22
AU2003253050A1 (en) 2004-02-02

Similar Documents

Publication Publication Date Title
AU2003235618A8 (en) Ultrasonic treatment of breast cancer
IL162201A0 (en) New methods for diagnosis and treatment of tumours
EP1551990A4 (en) Diagnosis and treatment of chemoresistant tumors
EP1571968A4 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1589933A4 (en) Compositions and methods for the diagnosis and treatment of tumor
HK1089107A1 (en) Delivery of therapeutic compounds to the brain and other tissues
SI1673104T1 (en) Delivery of therapeutic compounds to the brain and other tissues
EP1814909A4 (en) Use of aimp2dx2 for the diagnosis and treatment of cancer
EP1590433A4 (en) Diagnosis and prognosis of breast cancer patients
EP1553912A4 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1578996A4 (en) Compositions and methods for the diagnosis and treatment of tumor
HK1086193A1 (en) Prevention and treatment of breast cancer with 4-hydroxy tamoxifen 4-
EP1575571A4 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1539251A4 (en) Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesis
EP1636160A4 (en) Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders
EP1773882A4 (en) Diagnosis and treatment of siglec-6 associated diseases
ZA200510282B (en) Compositions and methods for the diagnosis and treatment of tumor
IL179560A0 (en) Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias
EP1420814A4 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2003237792A8 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1589980A4 (en) Methods of diagnosis and treatment of interstitial lung disease
ZA200610297B (en) Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias
EP1546714A4 (en) Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
AU2003253050A8 (en) Diagnosis and therapy of breast tumours resistant to antiestrogen treatment
GB0326578D0 (en) Cancer diagnosis and therapy

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase